Cargando…

ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma

The aim of this observational study was to test whether ABO blood type was a prognostic factor for pancreatic ductal adenocarcinoma (PDAC) patients and whether other risk factors could influence pancreatic cancer patients’ survival. This study included 610 patients who were diagnosed as pancreatic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shuang-Shuang, Zhou, Cong-Ya, Liao, Rong, Xiong, Lai, Weng, Ning-Na, Zhao, Ya-Qin, Mason, Clifford, Gou, Hong-Feng, Yi, Cheng, Zhu, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220786/ https://www.ncbi.nlm.nih.gov/pubmed/32243360 http://dx.doi.org/10.1097/MD.0000000000019413

Ejemplares similares

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

GLI1 expression in pancreatic ductal adenocarcinoma correlates the clinical significance and prognosis: A meta-analysis
por: Li, Ruidan, et al.
Publicado: (2020)

dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study
por: Xiong, Junjie, et al.
Publicado: (2016)

Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma
por: Kim, Hyoung Woo, et al.
Publicado: (2015)

Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma
por: Ji, Fei, et al.
Publicado: (2016)

The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma
por: Xu, Peng, et al.
Publicado: (2021)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Evaluation of ABO/Rh blood group distributions in papillary thyroid cancer patients
por: Dogan, Ozlem
Publicado: (2023)

ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma
por: Lin, Chao, et al.
Publicado: (2016)

Prognosis-related autophagy genes in female lung adenocarcinoma
por: Liu, Zhongxiang, et al.
Publicado: (2022)

Epidermal growth factor receptor-mutant pulmonary adenocarcinoma coexisting with tuberculosis: A case report
por: Liu, Ning, et al.
Publicado: (2021)

Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma
por: Xu, Dapeng, et al.
Publicado: (2022)

ABO and Rhesus blood group markers as predictors in colorectal cancer: A prospective observational study
por: Rashid, Gowhar, et al.
Publicado: (2023)

High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs
por: Deng, Chao, et al.
Publicado: (2019)

The prognosis of early-stage breast cancer in extremely young female patients
por: Chung, Wei-Pang, et al.
Publicado: (2021)

Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases
por: Yu, Ye, et al.
Publicado: (2020)

Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma
por: Luo, Xiao-Ye, et al.
Publicado: (2023)

Radiation-induced nausea and vomiting: Is ABO blood group as important as radiation and patient-related factors? An observational study
por: Habibi, Mohsen, et al.
Publicado: (2016)

Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article)
por: He, Qing-lin, et al.
Publicado: (2020)

Exploration of genes and tumor infiltrating lymphocytes in female lung adenocarcinoma microenvironment that predicted prognosis
por: Wang, Lijun, et al.
Publicado: (2021)

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023)

Identification of a new risk score model based on hypoxia and EMT-related genes for predicting lung squamous cell carcinoma prognosis
por: Zhuang, Xiaojie, et al.
Publicado: (2023)

Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern china: A 25-year retrospective study
por: Ouyang, Dai-qiao, et al.
Publicado: (2017)

Impact of heavy smoking on the benefits from first-line EGFR-TKI therapy in patients with advanced lung adenocarcinoma
por: Zhang, Ping, et al.
Publicado: (2018)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2022)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments
por: Zhao, Xiayan, et al.
Publicado: (2020)

Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China
por: Yan, Wenxing, et al.
Publicado: (2019)

Poorer prognosis in patients with advanced gastric squamous cell carcinoma compared with adenocarcinoma of the stomach: Case report
por: Meng, Ying, et al.
Publicado: (2017)

Soy food intake and risk of gastric cancer: A dose–response meta-analysis of prospective studies
por: Weng, Ke-Gui, et al.
Publicado: (2017)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma
por: Zhang, Weiyi
Publicado: (2023)

Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis
por: Tian, Jiangfang, et al.
Publicado: (2019)

Identification of potential serum exosomal microRNAs involved in acinar-ductal metaplasia that is a precursor of pancreatic cancer associated with chronic pancreatitis
por: Sheng, Li-Ping, et al.
Publicado: (2021)

High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis
por: Wu, Wei, et al.
Publicado: (2023)

NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden
por: Li, Zihao, et al.
Publicado: (2023)

A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
por: Ni, Lu, et al.
Publicado: (2021)

The predictive value of calcification for the grading of ductal carcinoma in situ in Chinese patients
por: Kong, Jianchun, et al.
Publicado: (2020)

Relationship between ABO blood group and risk of venous thrombosis in cancer patients with peripherally inserted central catheters: A protocol for systematic review and meta-analysis
por: Liu, Fangjing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmlf2vjnfgui4cr4s208lfu3od